[eDisclosure Notice] Samchundang Pharmaceutical Halts Negotiations on 300 Billion KRW Oral Vaccine Investment with Global Pharma (Afternoon Summary)
[Asia Economy Reporter Minji Lee] Samchundang Pharmaceutical announced on the 2nd that it has suspended negotiations after a global pharmaceutical partner informed them that continued development is difficult considering the demand and growth potential of the COVID-19 vaccine market, despite having negotiated a 300 billion KRW investment with global pharmaceutical companies in May last year to develop the world's best oral COVID-19 vaccine.
▲ Megastudy = Announced that the largest shareholder has ultimately decided not to sell shares to MBK Partners.
▲ Melpas = Announced that Cheongun Partners has filed a provisional injunction for suspension of duties at the Suwon District Court Seongnam Branch.
▲ Hanwha = Announced the appointment of Kim Dong-kwan as the new CEO, changing to a multiple CEO system with Geum Chun-soo, Kim Dong-kwan, Ok Kyung-seok, and Kim Seung-mo.
Hot Picks Today
"Now Our Salaries Are 10 Million Won a Month" Record High... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Living the Homebody Dream? "I Was Shocked by My Spending" How to Cut Costs to 5,000 Won for Essentials [The Principles of Benefits]
- Is It Really Like an Illness? "I Can't Wait to Go Again"—Over 1 Million Visited in Q1, Now 'Busanbyeong' Takes Hold [K-Holic]
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- Experts Already Watching Closely..."Target Price Set at 970,000 Won" Only Upward Momentum Remains [Weekend Money]
▲ AK Holdings = Announced the decision to issue 130 billion KRW worth of anonymous, unsecured private exchangeable bonds to raise funds for acquiring securities of other companies.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
